Due to the low number of RIP MSI mutated samples, this difference between MLH1 proficient and deficient tumors, although highly significant, needs to be validated in further studies.
← all excerpts
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors.
1
—
—